Skip to main content

Table 2 Demographics, RHC, Echocardiography and CMR Data

From: Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry

  No PH n = 39 PH n = 194
Demographics
Age (yrs) 61 ± 16 63 ± 15
Female (%) 56% 59%
WHO class I   3 (1.5%)
 II   42 (21.6%)
 III   127 (65.5%)
 IV   22 (11.3%)
Invasive catheter measurements
mRAP (mmHg) 6 ± 3 11 ± 5†
mPAP (mmHg) 19 ± 3 45 ± 12†
PCWP (mmHg) 11 ± 5 12 ± 6
CO (L.min) 7.0 ± 1.8 5.1 ± 1.7†
CI (L.min.m-2) 3.7 ± 0.7 2.9 ± 0.9†
PVR (dyn.s.cm-5) 149 ± 167 587 ± 411†
Mixed VO2 (%) 73.5 ± 6.3 63.8 ± 9.2†
Echocardiography (n = 195)
TRJV (cm/s) 2.6 ± 0.6 3.9 ± 0.9†
Echo derived mPAP (mmHg) 25.4 ± 7.6 46.8 ± 16.6†
MR – RV morphology
RVEDVI (ml/m2) 77.7 ± 24.6 99.1 ± 39.0†
RV mass index (g/m2) 13.7 ± 6.92 37.6 ± 18.7†
VMI (ratio) 0.26 ± 0.11 0.70 ± 0.35†
Late gadolinium enhancement, ratio and % (n = 159) 2/31 (6%) 108/128 (86%)
MR – RV function
RVEF (%) 39.7 ± 14.5 28.2 ± 14.5†
RVSVI (ml/m2) 31.4 ± 13.3 23.3 ± 13.2†
TAPSE (cm) 2.21 ± 0.66 1.55 ± 0.76†
f-TAAD (%) 24.6 ± 7.89 15.9 ± 7.49†
SFD (cm) 1.10 ± 0.45 0.64 ± 0.52†
f-SFD (%) 27.1 ± 11.5 14.4 ± 12.3†
RVRAC (%) 39.8 ± 10.5 26.2 ± 13.4†
sEI (ratio) 1.19 ± 0.19 1.57 ± 0.52†
dEI (ratio) 1.17 ± 0.12 1.28 ± 0.23
Phase contrast – Pulmonary artery (n = 106)
Average velocity (cm/s) 13.6 ± 6.7 7.6 ± 3.4†
Retrograde flow (L/min/m2) 0.2 ± 0.1 0.5 ± 0.3†
Retrograde flow (%) 9.3 ± 7.2 16.3 ± 9.2†
PA relative area change ≥ 15% 17.8 ± 6.6 8.1 ± 6.5†
Systolic PA area (cm2) 7.8 ± 4.6 9.7 ± 2.8†
Diastolic PA area (cm2) 6.7 ± 4.7 8.9 ± 2.8†
  1. Mean ± SD values displayed, † tested value significantly different in the PH patient group than in the ‘No PH’ group (p < 0.05).